期刊文献+

甲型流感病毒核蛋白在大肠杆菌中的可溶性高效表达与纯化 被引量:4

Efficient Soluble Expression and Purification of Influenza A Nucleoprotein in Escherichia coli
原文传递
导出
摘要 为了在大肠杆菌中高效表达甲型流感病毒A/京科/30/95(H3N2)核蛋白NP,以便对原核表达的NP蛋白进行免疫原性研究,本研究通过密码子优化及全基因合成等方法,将3种形式的NP基因:与6×His标签融合的NP基因NP(His)、非融合的野生型NP基因NPwt及非融合的按大肠杆菌优势密码子改造的基因NP(O)分别插入原核表达载体pET-30a,构建了表达3种形式NP基因的3种原核表达质粒并研究不同质粒中NP蛋白的表达形式、条件、纯化工艺及抗原性。限制性酶切反应与测序表明,三种形式的NP基因均正确插入原核表达质粒pET-30a;SDS-PAGE凝胶电泳显示,三种形式的NP基因均能在大肠杆菌中表达,NP(O)基因的表达量最高;在不同温度诱导条件下,NP蛋白呈现可溶性表达,NP(O)基因可溶性高效表达的条件为:T=25℃,t=10 h;经阴离子交换和凝胶过滤层析两步纯化,可溶性表达的NP蛋白纯度可达90%;Western blot检测显示,纯化的NP能与流感病毒A/PR/8/34(H1N1)株感染小鼠的血清发生特异性结合。这些结果表明,非融合表达的密码子优化甲型流感病毒NP蛋白能在大肠杆菌中高效表达和纯化,同时保持良好的免疫反应活性。 To efficiently express nucleoprotein (NP) of influenza A virus A/Jingke/30/95 (H3N2) in E. coli for further immunogenicity study, three forms of NP gene, NP(His) (NP fused with 6×His tag), NPwt(wild type NP, non-fused NP with native codon) and NP(O) (codon optimized, non-fused NP) were cloned by the technologies of restriction enzyme digestion, PCR, codon optimization and gene synthesis. Three recombinant plasmids were subsequently constructed based on the prokaryotic vector pET-30a, respectively. The comparative studies with these plasmids were carried out on the gene expression efficiency, induction temperature and time, purification process and immune reactivity. It was confirmed by restriction enzyme digestion and sequencing analysis that the three NP genes were inserted into the expression plasmid pET-30a correctly. SDS-PAGE showed that all three forms of NP gene could be efficiently expressed in E. coli, among which NP(O) was expressed with the highest expression level. The lower temperature fermentation (T= 25℃ ) and longer time induction (t= 10 h) were necessary for high-level expres- sion of protein in soluble form. The purity of tag-free NP was up to 90% through the two-step purification process with anion-exchange and gel filtration chromatography. It was indicated by Western blot that purified NP reacted well with the serum from mice immunized with PR8 virus. These results suggest that the codon-optimized influenza A virus NP gene can be efficiently expressed in E. coli and the expressed NP protein with specific immune reactivity could be purified from the supernatant of bacterial lysate.
出处 《病毒学报》 CAS CSCD 北大核心 2011年第1期50-57,共8页 Chinese Journal of Virology
基金 国家863计划资助(2006AA02A203)
关键词 甲型流感病毒 核蛋白 原核系统 密码子优化 蛋白质表达 influenza A virus nucleoprotein prokaryotic system eodon optimization protein expression
  • 相关文献

参考文献25

  • 1Webster R G, Russell C J. The Genesis of a pandemic influenza virus [J]. Cell, 2005, 123(3): 368-371.
  • 2Luke C J, Subbarao K. Vaccines for pandemic influenza [J]. Emerg Infect Dis, 2006, 12(1):66-72.
  • 3Gerdil C. The annual production cycle for influenza vaccine[J]. Vaccine, 2003, 21(16) :1776-1779.
  • 4Fedson D S. Preparing for pandemic vaccination: an international policy agenda for vaccine development [J]. J Public Health Policy, 2005, 26(1): 4-29.
  • 5Palese P. Making better influenza virus vaccines? [J].Emerg Infect Dis, 2006, 12(1):61-65.
  • 6Shu L L, Bean W J, Webster R G. Analysis of the evolution and variation of the human influenza A virus nu- eleoprotein gene from 1933 to 1990 [J]. J Virol, 1993, 67(5) :2723-2729.
  • 7Michael A J, Gotch F M, Noble G R, et al. Cytotoxic T-cell immunity to influenza[J].N Engl J Med, 1983, 309(1) :13-17.
  • 8Epstein S L, Kong W P, Misplon J A, et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nueleoprotein [J]. Vaccine, 2005, 23(46-47) : 5401-5410.
  • 9李仁清.甲型流感病毒非主要保护抗原的免疫学特性的研究[D].北京:中国疾病预防控制中心病毒病预防控制所,2006年.
  • 10Altstein A D, Gitelman A K, Smirnov Y A, et al. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental in fection with human and avian influenza viruses [J]. Arch Virol, 2006, 151(5):921-931.

二级参考文献16

共引文献7

同被引文献23

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部